Search research articles
Contact Us
Filters
Showing results (11-20 of 65) with videos related to
Page
of 7
Sort By:
Expert Opinion on Pharmacotherapy
|
June 17, 2005
Perspectives on novel therapies for bronchial carcinoma
Fiona Blackhall, Pavlos I Papakotoulas, Sarah Danson, et al.
The Lancet. Oncology
|
October 7, 2004
Assessment of therapeutic response in patients with metastatic bone disease
Andrew Clamp, Sarah Danson, Huy Nguyen, et al.
International Journal of Oncology
|
September 7, 2011
Treatment with the Chk1 inhibitor Gö6976 enhances cisplatin cytotoxicity in SCLC cells
Ruth Thompson, Mark Meuth, Penella Woll, et al.
Lancet (London, England)
|
August 28, 2015
Effect of methotrexate on JAK/STAT pathway activation in myeloproliferative neoplasms
Sally Thomas, Katherine Fisher, John Snowden, et al.
Biomolecules
|
May 4, 2026
Exercise Boosts the Immune System and Enhances Immunotherapy Responses in Pancreatic Cancer and Mesothelioma
Brindley Hapuarachi, Sarah Danson, Jonathan Wadsley, et al.
Immunotherapy Advances
|
January 12, 2026
The UK vaccine innovation pathway
Sarah Danson, Robert P Jones, Kristina Duggleby, et al.
Journal of Comorbidity
|
November 2, 2017
The acute oncologist's role in managing patients with cancer and other comorbidities
Kate Shankland, Peter Kirkbride, Anne-Marie Bourke, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 6, 2007
DHA-paclitaxel (Taxoprexin) as first-line treatment in patients with stage IIIB or IV non-small cell lung cancer: report of a phase II open-label multicenter trial
Miranda Payne, Paul Ellis, David Dunlop, et al.
British Journal of Health Psychology
|
June 12, 2025
Assessing moral injury in health care workers living in secular societies: Introducing the Health care-Moral Injury Scale (HMIS)
Kathryn Fradley, Fuschia Sirois, Richard Bentall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 2007
Combination therapy with gefitinib and rofecoxib in patients with platinum-pretreated relapsed non small-cell lung cancer
Kenneth J O'Byrne, Sarah Danson, David Dunlop, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 65) with videos related to
Sort By:
Page
of 7
Expert Opinion on Pharmacotherapy
|
June 17, 2005
Perspectives on novel therapies for bronchial carcinoma
Fiona Blackhall, Pavlos I Papakotoulas, Sarah Danson, et al.
The Lancet. Oncology
|
October 7, 2004
Assessment of therapeutic response in patients with metastatic bone disease
Andrew Clamp, Sarah Danson, Huy Nguyen, et al.
International Journal of Oncology
|
September 7, 2011
Treatment with the Chk1 inhibitor Gö6976 enhances cisplatin cytotoxicity in SCLC cells
Ruth Thompson, Mark Meuth, Penella Woll, et al.
Lancet (London, England)
|
August 28, 2015
Effect of methotrexate on JAK/STAT pathway activation in myeloproliferative neoplasms
Sally Thomas, Katherine Fisher, John Snowden, et al.
Biomolecules
|
May 4, 2026
Exercise Boosts the Immune System and Enhances Immunotherapy Responses in Pancreatic Cancer and Mesothelioma
Brindley Hapuarachi, Sarah Danson, Jonathan Wadsley, et al.
Immunotherapy Advances
|
January 12, 2026
The UK vaccine innovation pathway
Sarah Danson, Robert P Jones, Kristina Duggleby, et al.
Journal of Comorbidity
|
November 2, 2017
The acute oncologist's role in managing patients with cancer and other comorbidities
Kate Shankland, Peter Kirkbride, Anne-Marie Bourke, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 6, 2007
DHA-paclitaxel (Taxoprexin) as first-line treatment in patients with stage IIIB or IV non-small cell lung cancer: report of a phase II open-label multicenter trial
Miranda Payne, Paul Ellis, David Dunlop, et al.
British Journal of Health Psychology
|
June 12, 2025
Assessing moral injury in health care workers living in secular societies: Introducing the Health care-Moral Injury Scale (HMIS)
Kathryn Fradley, Fuschia Sirois, Richard Bentall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 2007
Combination therapy with gefitinib and rofecoxib in patients with platinum-pretreated relapsed non small-cell lung cancer
Kenneth J O'Byrne, Sarah Danson, David Dunlop, et al.
Page
of 7